In Australia, Transcranial Magnetic Stimulation (TMS) is approved for treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from at least two prior antidepressant medications at or above the minimal effective dose and duration in the current episode. TMS involves applying brief pulses of magnetic energy to a specified area of the brain to modulate the activity of underlying brain cells. In a usual course of treatment, a patient will have 20 sessions of TMS over 4 weeks. Previously, the other treatment option for patients was to undergo Electroconvulsive Therapy (ECT).
Transcranial Magnetic Stimulation
Initiative Type
Technology
Status
Deliver
Added
Last updated
Summary
Key dates
Apr 2014
Jan 2018
Implementation sites
Metro South Addiction and Mental Health Services
Aim
Provides an opportunity to pilot and evaluate new technologies within 'real world' clinical settings in the Queensland context.
Benefits
- Delivered in an out-patient setting compared to ECT which is performed in an operating theatre.
- Non-invasive and well tolerated by patients.
Background
This technology was funded through the New Technology Funding and Evaluation Program (NTFEP). The NTFEP funds the introduction and evaluation of new technologies that:
- Are safe and effective
- Provide better health outcomes
- Provide value for money
- Provide greater access to care.
The evaluation findings will inform recommendations regarding the future use and/or investment of the technology within Queensland.
